DRD2 and Hyperglycemia: Moreover, hyperglycemia induced by systemic injection of quinpirole was inhibited by the centrally acting dopamine D2 receptor antagonist haloperidol, but not by the peripheral acting dopamine D2 receptor antagonist domperidone18.